Consensus guidelines for the treatment of atopic dermatitis in Korea (part I)

General management and topical treatment

Jung Eun Kim, Hyun Jeong Kim, Bark Lynn Lew, Kyung Ho Lee, Seung Phil Hong, Yong Hyun Jang, Kui Young Park, Seong Jun Seo, Jung Min Bae, Eung Ho Choi, Ki Beom Suhr, Seung Chul Lee, Hyun Chang Ko, Young Lip Park, Sang Wook Son, Young Jun Seo, Yang Won Lee, Sang Hyun Cho, Chun Wook Park, Joo Young Roh

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Background: Since the treatment guidelines for atopic dermatitis (AD) were released by the Korean Atopic Dermatitis Association (KADA) work group in 2006, there have been several advances in AD management. Objective: We aimed to establish updated evidence- and experience-based treatment guidelines for Korean AD. Methods: We collected a database of references from relevant systematic AD reviews and guidelines regarding general AD management such as bathing and skin care, avoidance of exacerbating factors, education and psychosocial support, and the use of moisturizers and topical anti-inflammatory and antipruritic drugs. Evidence for each statement was graded and the strength of the recommendation for each statement classified. Thirty-nine KADA council members participated in three rounds of voting to establish an expert consensus of recommendations. Results: Basic AD treatment includes proper bathing and skin care, avoidance of exacerbating factors, proper education and psychosocial support, and use of moisturizers. The regular use of moisturizer has a steroid-sparing effect and reduces relapse episodes. The short- and long-term use of topical corticosteroids and calcineurin inhibitors improves AD symptoms and should be encouraged to use in an active and proactive treatment. Wet-wrap therapy can be used for rapid recovery of acute exacerbation. Topical antipruritic drugs cannot be recommended for the treatment of AD. Conclusion: This report provides up-to-date evidence- and experience- based treatment guidelines for AD regarding general management and topical treatment. In addition, the average agreement scores obtained by a panel of experts based on the Korean healthcare system and patient adherence are presented.

Original languageEnglish
Pages (from-to)563-577
Number of pages15
JournalAnnals of Dermatology
Volume27
Issue number5
DOIs
Publication statusPublished - 2015 Oct 1

Fingerprint

Atopic Dermatitis
Korea
Consensus
Guidelines
Antipruritics
Therapeutics
Skin Care
Education
Politics
Patient Compliance
Adrenal Cortex Hormones
Anti-Inflammatory Agents
Steroids
Databases
Psychology
Delivery of Health Care
Recurrence

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Kim, Jung Eun ; Kim, Hyun Jeong ; Lew, Bark Lynn ; Lee, Kyung Ho ; Hong, Seung Phil ; Jang, Yong Hyun ; Park, Kui Young ; Seo, Seong Jun ; Bae, Jung Min ; Choi, Eung Ho ; Suhr, Ki Beom ; Lee, Seung Chul ; Ko, Hyun Chang ; Park, Young Lip ; Son, Sang Wook ; Seo, Young Jun ; Lee, Yang Won ; Cho, Sang Hyun ; Park, Chun Wook ; Roh, Joo Young. / Consensus guidelines for the treatment of atopic dermatitis in Korea (part I) : General management and topical treatment. In: Annals of Dermatology. 2015 ; Vol. 27, No. 5. pp. 563-577.
@article{e2e6047ddccb4b358bc57f4f4bf1ab0c,
title = "Consensus guidelines for the treatment of atopic dermatitis in Korea (part I): General management and topical treatment",
abstract = "Background: Since the treatment guidelines for atopic dermatitis (AD) were released by the Korean Atopic Dermatitis Association (KADA) work group in 2006, there have been several advances in AD management. Objective: We aimed to establish updated evidence- and experience-based treatment guidelines for Korean AD. Methods: We collected a database of references from relevant systematic AD reviews and guidelines regarding general AD management such as bathing and skin care, avoidance of exacerbating factors, education and psychosocial support, and the use of moisturizers and topical anti-inflammatory and antipruritic drugs. Evidence for each statement was graded and the strength of the recommendation for each statement classified. Thirty-nine KADA council members participated in three rounds of voting to establish an expert consensus of recommendations. Results: Basic AD treatment includes proper bathing and skin care, avoidance of exacerbating factors, proper education and psychosocial support, and use of moisturizers. The regular use of moisturizer has a steroid-sparing effect and reduces relapse episodes. The short- and long-term use of topical corticosteroids and calcineurin inhibitors improves AD symptoms and should be encouraged to use in an active and proactive treatment. Wet-wrap therapy can be used for rapid recovery of acute exacerbation. Topical antipruritic drugs cannot be recommended for the treatment of AD. Conclusion: This report provides up-to-date evidence- and experience- based treatment guidelines for AD regarding general management and topical treatment. In addition, the average agreement scores obtained by a panel of experts based on the Korean healthcare system and patient adherence are presented.",
author = "Kim, {Jung Eun} and Kim, {Hyun Jeong} and Lew, {Bark Lynn} and Lee, {Kyung Ho} and Hong, {Seung Phil} and Jang, {Yong Hyun} and Park, {Kui Young} and Seo, {Seong Jun} and Bae, {Jung Min} and Choi, {Eung Ho} and Suhr, {Ki Beom} and Lee, {Seung Chul} and Ko, {Hyun Chang} and Park, {Young Lip} and Son, {Sang Wook} and Seo, {Young Jun} and Lee, {Yang Won} and Cho, {Sang Hyun} and Park, {Chun Wook} and Roh, {Joo Young}",
year = "2015",
month = "10",
day = "1",
doi = "10.5021/ad.2015.27.5.563",
language = "English",
volume = "27",
pages = "563--577",
journal = "Annals of Dermatology",
issn = "1013-9087",
publisher = "Korean Dermatological Association",
number = "5",

}

Kim, JE, Kim, HJ, Lew, BL, Lee, KH, Hong, SP, Jang, YH, Park, KY, Seo, SJ, Bae, JM, Choi, EH, Suhr, KB, Lee, SC, Ko, HC, Park, YL, Son, SW, Seo, YJ, Lee, YW, Cho, SH, Park, CW & Roh, JY 2015, 'Consensus guidelines for the treatment of atopic dermatitis in Korea (part I): General management and topical treatment', Annals of Dermatology, vol. 27, no. 5, pp. 563-577. https://doi.org/10.5021/ad.2015.27.5.563

Consensus guidelines for the treatment of atopic dermatitis in Korea (part I) : General management and topical treatment. / Kim, Jung Eun; Kim, Hyun Jeong; Lew, Bark Lynn; Lee, Kyung Ho; Hong, Seung Phil; Jang, Yong Hyun; Park, Kui Young; Seo, Seong Jun; Bae, Jung Min; Choi, Eung Ho; Suhr, Ki Beom; Lee, Seung Chul; Ko, Hyun Chang; Park, Young Lip; Son, Sang Wook; Seo, Young Jun; Lee, Yang Won; Cho, Sang Hyun; Park, Chun Wook; Roh, Joo Young.

In: Annals of Dermatology, Vol. 27, No. 5, 01.10.2015, p. 563-577.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Consensus guidelines for the treatment of atopic dermatitis in Korea (part I)

T2 - General management and topical treatment

AU - Kim, Jung Eun

AU - Kim, Hyun Jeong

AU - Lew, Bark Lynn

AU - Lee, Kyung Ho

AU - Hong, Seung Phil

AU - Jang, Yong Hyun

AU - Park, Kui Young

AU - Seo, Seong Jun

AU - Bae, Jung Min

AU - Choi, Eung Ho

AU - Suhr, Ki Beom

AU - Lee, Seung Chul

AU - Ko, Hyun Chang

AU - Park, Young Lip

AU - Son, Sang Wook

AU - Seo, Young Jun

AU - Lee, Yang Won

AU - Cho, Sang Hyun

AU - Park, Chun Wook

AU - Roh, Joo Young

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: Since the treatment guidelines for atopic dermatitis (AD) were released by the Korean Atopic Dermatitis Association (KADA) work group in 2006, there have been several advances in AD management. Objective: We aimed to establish updated evidence- and experience-based treatment guidelines for Korean AD. Methods: We collected a database of references from relevant systematic AD reviews and guidelines regarding general AD management such as bathing and skin care, avoidance of exacerbating factors, education and psychosocial support, and the use of moisturizers and topical anti-inflammatory and antipruritic drugs. Evidence for each statement was graded and the strength of the recommendation for each statement classified. Thirty-nine KADA council members participated in three rounds of voting to establish an expert consensus of recommendations. Results: Basic AD treatment includes proper bathing and skin care, avoidance of exacerbating factors, proper education and psychosocial support, and use of moisturizers. The regular use of moisturizer has a steroid-sparing effect and reduces relapse episodes. The short- and long-term use of topical corticosteroids and calcineurin inhibitors improves AD symptoms and should be encouraged to use in an active and proactive treatment. Wet-wrap therapy can be used for rapid recovery of acute exacerbation. Topical antipruritic drugs cannot be recommended for the treatment of AD. Conclusion: This report provides up-to-date evidence- and experience- based treatment guidelines for AD regarding general management and topical treatment. In addition, the average agreement scores obtained by a panel of experts based on the Korean healthcare system and patient adherence are presented.

AB - Background: Since the treatment guidelines for atopic dermatitis (AD) were released by the Korean Atopic Dermatitis Association (KADA) work group in 2006, there have been several advances in AD management. Objective: We aimed to establish updated evidence- and experience-based treatment guidelines for Korean AD. Methods: We collected a database of references from relevant systematic AD reviews and guidelines regarding general AD management such as bathing and skin care, avoidance of exacerbating factors, education and psychosocial support, and the use of moisturizers and topical anti-inflammatory and antipruritic drugs. Evidence for each statement was graded and the strength of the recommendation for each statement classified. Thirty-nine KADA council members participated in three rounds of voting to establish an expert consensus of recommendations. Results: Basic AD treatment includes proper bathing and skin care, avoidance of exacerbating factors, proper education and psychosocial support, and use of moisturizers. The regular use of moisturizer has a steroid-sparing effect and reduces relapse episodes. The short- and long-term use of topical corticosteroids and calcineurin inhibitors improves AD symptoms and should be encouraged to use in an active and proactive treatment. Wet-wrap therapy can be used for rapid recovery of acute exacerbation. Topical antipruritic drugs cannot be recommended for the treatment of AD. Conclusion: This report provides up-to-date evidence- and experience- based treatment guidelines for AD regarding general management and topical treatment. In addition, the average agreement scores obtained by a panel of experts based on the Korean healthcare system and patient adherence are presented.

UR - http://www.scopus.com/inward/record.url?scp=84943793988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943793988&partnerID=8YFLogxK

U2 - 10.5021/ad.2015.27.5.563

DO - 10.5021/ad.2015.27.5.563

M3 - Review article

VL - 27

SP - 563

EP - 577

JO - Annals of Dermatology

JF - Annals of Dermatology

SN - 1013-9087

IS - 5

ER -